Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 13 studies | 29% ± 10% | |
epithelial cell | 10 studies | 34% ± 11% | |
enterocyte | 7 studies | 36% ± 9% | |
secretory cell | 5 studies | 27% ± 8% | |
squamous epithelial cell | 4 studies | 33% ± 19% | |
brush cell | 4 studies | 26% ± 6% | |
pancreatic A cell | 3 studies | 23% ± 8% | |
goblet cell | 3 studies | 19% ± 2% | |
progenitor cell | 3 studies | 21% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
intestine | 3 studies | 20% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 75% | 1225.01 | 269 / 359 | 97% | 132.30 | 276 / 286 |
liver | 92% | 1221.28 | 209 / 226 | 78% | 66.89 | 317 / 406 |
thymus | 96% | 696.65 | 630 / 653 | 68% | 16.80 | 414 / 605 |
lung | 81% | 567.68 | 471 / 578 | 74% | 51.59 | 853 / 1155 |
intestine | 51% | 3570.83 | 488 / 966 | 98% | 147.01 | 514 / 527 |
prostate | 48% | 312.64 | 117 / 245 | 77% | 52.85 | 386 / 502 |
bladder | 48% | 935.33 | 10 / 21 | 76% | 75.98 | 385 / 504 |
esophagus | 40% | 1992.11 | 578 / 1445 | 74% | 83.12 | 136 / 183 |
kidney | 98% | 798.90 | 87 / 89 | 8% | 2.41 | 73 / 901 |
pancreas | 7% | 19.73 | 24 / 328 | 84% | 57.46 | 149 / 178 |
breast | 41% | 328.57 | 187 / 459 | 42% | 16.08 | 474 / 1118 |
skin | 72% | 1497.02 | 1302 / 1809 | 3% | 0.93 | 16 / 472 |
tonsil | 0% | 0 | 0 / 0 | 51% | 16.71 | 23 / 45 |
peripheral blood | 50% | 342.45 | 462 / 929 | 0% | 0 | 0 / 0 |
uterus | 4% | 67.60 | 6 / 170 | 46% | 20.77 | 210 / 459 |
adrenal gland | 1% | 7.24 | 3 / 258 | 35% | 14.19 | 81 / 230 |
ovary | 0% | 0 | 0 / 180 | 31% | 8.42 | 135 / 430 |
spleen | 10% | 27.74 | 23 / 241 | 0% | 0 | 0 / 0 |
brain | 3% | 7.75 | 76 / 2642 | 0% | 0.02 | 1 / 705 |
adipose | 0% | 4.11 | 6 / 1204 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.94 | 2 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0.94 | 2 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045087 | Biological process | innate immune response |
GO_0010008 | Cellular component | endosome membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | TMEM45B |
Protein name | Transmembrane protein 45B |
Synonyms | |
Description | FUNCTION: Plays a role in innate immunity . Mechanistically, promotes alphaviruses RNA degradation by interacting with the viral polymerase nsP4 and the mRNA-capping enzyme nsP1 and thereby interfering with the interaction between viral RNA and nsP1.. . |
Accessions | ENST00000281441.8 Q96B21 ENST00000524567.1 |